Evidence map›Paper›PMID 41458484›Full record

ReviewFrontiers in medicine2025

The evolution and application of the medical evidence chain.

Yanan Bai, Wanying Wang, Jiajia Duan, Xue Wang, Mingjing Jiang, Han Ni, Lu Sun, Chuanxin Liu, Ding Li

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yanan Bai *School of Law, Xiamen University, Xiamen, China.
Wanying Wang *Luoyang Key Laboratory of Clinical Multiomics and Translational Medicine, Henan Key Laboratory of Rare Diseases, Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Jiajia DuanDepartment of Clinical Laboratory, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Xue WangState Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Mingjing JiangSchool of Law, Zhongyuan University of Technology, Zhengzhou, China.
Han NiSchool of Law, Zhongyuan University of Technology, Zhengzhou, China.
Lu SunCollege of Chinese Materia Medica and Food Engineering, Shanxi University of Chinese Medicine, Jinzhong, China.
Chuanxin LiuLuoyang Key Laboratory of Clinical Multiomics and Translational Medicine, Henan Key Laboratory of Rare Diseases, Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Ding LiDepartment of Pharmacy, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, HNHC Key Laboratory of Anti-tumor Drug Research, Henan Engineering Research Center for Tumor Precision Medicine and Comprehensive Evaluation, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Since the advent of evidence-based medicine, the decision-making process in disease diagnosis and treatment has exhibited fundamental principles that align closely with the core tenets of evidence chain theory in the legal field. Based on this, this paper aims to explore the underlying logic and practical value of transferring evidence chain theory from law to medicine, focusing on its significance in enhancing the scientific rigor and standardization of clinical decision-making. Methods: Through systematic retrieval of existing literature in the fields of jurisprudence and medicine, this paper reviewed the theoretical evolution and practical applications of the evidence chain in jurisprudence, outlined the grading criteria for medical evidence, and elaborated on the construction methods and application examples of the integrated evidence chain and toxicological evidence chain. Results: The mutual corroboration among evidence materials significantly enhances the reliability and validity of conclusions. The theory of evidence chains plays a pivotal role in evaluating drug efficacy, elucidating toxicological mechanisms, optimizing clinical pathways, and designing high-quality clinical trials. Conclusion: The interdisciplinary application of the evidence chain theory contributes to advancing the standardization and normalization of evidence-based medical practice, thereby enhancing the quality of clinical decision-making and public health management.

Indexed as

connecting pointscorroborationevidence-based medicineevidence chainGRADEintegrated evidence chain

Identifiers

PMID41458484
PMCPMC12738915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.